- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Environmentally-Friendly
Swedish Pharmaceuticals & Biotech Environmentally-Friendly
UPDATED Mar 10, 2024
Investing in companies that think about the future will generate eco-friendly products and sustainable returns. As consumers become more environmentally-aware, demand will increase for these companies' products.
124 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CALTXCalliditas Therapeutics | kr115.20 | 3.4% | 23.6% | kr6.2b | kr208.00 | PS5.1x | E48.2% | n/a | ||
| INITInitiator Pharma | kr8.90 | -1.1% | 48.6% | kr498.8m | kr23.99 | PB34.2x | E72.6% | n/a | ||
| CAMXCamurus | kr493.00 | 5.2% | 115.3% | kr28.4b | kr577.17 | PE65.8x | E50.0% | n/a | ||
| KANKancera | kr1.85 | -10.6% | -44.7% | kr150.8m | kr5.00 | PB3.2x | E131.9% | n/a | ||
| DVYSRDevyser Diagnostics | kr90.20 | -0.9% | 12.8% | kr1.5b | kr115.39 | PS8.7x | E99.3% | n/a | ||
| SPAGOSpago Nanomedical | kr0.31 | 5.1% | -61.3% | kr69.4m | kr1.48 | PS11.7x | E48.9% | n/a | ||
| XBRANEXbrane Biopharma | kr0.80 | 17.6% | -99.0% | kr23.8m | kr61.38 | PB0.1x | E126.0% | n/a | ||
| BINVBioInvent International | kr16.82 | 1.2% | -41.2% | kr1.1b | kr108.50 | PS15.5x | E60.1% | n/a | ||
| BIOA BBioArctic | kr233.20 | 6.4% | -10.7% | kr20.6b | kr366.20 | PE89.8x | E48.2% | 0% | ||
| EGTXEgetis Therapeutics | kr6.50 | -1.7% | 26.2% | kr1.9b | kr13.13 | PS33x | E87.5% | n/a | ||
| BIOVIC BBiovica International | kr2.35 | 9.8% | -72.1% | kr197.1m | kr18.00 | PS27.4x | E77.8% | n/a | ||
| BONEXBonesupport Holding | kr218.20 | 11.6% | 172.8% | kr14.2b | kr273.67 | PE57.9x | E14.0% | n/a | ||
| SENZASenzaGen | kr6.56 | 10.8% | -37.8% | kr158.7m | kr17.75 | PS3.5x | E111.3% | n/a | ||
| ENZYEnzymatica | kr3.06 | 0.8% | -3.9% | kr501.8m | kr5.98 | PS9.9x | E88.8% | n/a | ||
| RLSRLS Global | kr0.45 | -0.2% | -84.2% | kr35.6m | kr7.00 | PS33.1x | E92.8% | n/a | ||
| MOBMoberg Pharma | kr16.10 | -4.7% | -41.8% | kr450.2m | kr23.00 | PB0.7x | E47.6% | n/a | ||
| ALIF BAddLife | kr104.60 | 2.1% | 0.3% | kr12.7b | kr136.50 | PE67.1x | E34.4% | 0.5% | ||
| VITRVitrolife | kr200.00 | 8.7% | -9.7% | kr27.1b | kr248.33 | PS7.7x | E102.0% | 0.5% | ||
| MAGLEMagle Chemoswed Holding | kr25.40 | -0.8% | 0% | kr274.3m | kr40.00 | PE22.5x | E41.2% | 1.4% | ||
| GENOGenovis AB (publ.) | kr37.75 | -1.6% | -33.2% | kr2.5b | kr68.00 | PE40.2x | E3.3% | n/a | ||
| KLARKlaria Pharma Holding AB (publ.) | kr0.35 | -16.3% | -52.7% | kr37.2m | kr1.00 | PS163x | E29.9% | n/a | ||
| PROBProbi | kr220.00 | 7.3% | 19.8% | kr2.5b | n/a | PE149x | E39.7% | 0.6% | ||
| IMMUMendus | kr0.49 | -0.1% | -70.2% | kr422.5m | kr1.80 | PS14.3x | E61.5% | n/a | ||
| BICOBICO Group | kr44.16 | 4.8% | -33.8% | kr3.1b | kr132.50 | PS1.3x | E148.8% | n/a |